Long Term Outcomes of Patients with Aggressive T-Cell Non-Hodgkin Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from Single Center. | Zendy

Amandeep Salhotra | Zendy; Liaikolaenko | Zendy; Lu Chen | Zendy; NiChun Tsai | Zendy; David L. Smith | Zendy; Auayporn Nademanee | Zendy; Leslie Popplewell | Zendy; Alex F. Herrera | Zendy; Matthew Mei | Zendy; Stephen J. Forman | Zendy; Jasmine Zain | Zendy

Open Access

Long Term Outcomes of Patients with Aggressive T-Cell Non-Hodgkin Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from Single Center.

Author(s) -

Amandeep Salhotra,

Liaikolaenko,

Lu Chen,

NiChun Tsai,

David L. Smith,

Auayporn Nademanee,

Leslie Popplewell,

Alex F. Herrera,

Matthew Mei,

Stephen J. Forman,

Jasmine Zain

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.499

Subject(s) - medicine , melphalan , transplantation , fludarabine , regimen , cumulative incidence , salvage therapy , hematopoietic stem cell transplantation , aggressive lymphoma , lymphoma , oncology , retrospective cohort study , log rank test , survival analysis , surgery , chemotherapy , rituximab , cyclophosphamide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research